nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—HTR2C—Sorafenib—liver cancer	0.197	0.458	CbGbCtD
Escitalopram—CYP2C19—Sorafenib—liver cancer	0.0778	0.181	CbGbCtD
Escitalopram—CYP2D6—Sorafenib—liver cancer	0.0591	0.137	CbGbCtD
Escitalopram—CYP3A4—Sorafenib—liver cancer	0.0376	0.0874	CbGbCtD
Escitalopram—CYP2D6—Doxorubicin—liver cancer	0.0359	0.0834	CbGbCtD
Escitalopram—CYP3A4—Doxorubicin—liver cancer	0.0228	0.053	CbGbCtD
Escitalopram—Citalopram—CYP2E1—liver cancer	0.00729	1	CrCbGaD
Escitalopram—Orthostatic hypotension—Doxorubicin—liver cancer	0.000359	0.000791	CcSEcCtD
Escitalopram—Abdominal pain upper—Doxorubicin—liver cancer	0.000359	0.000791	CcSEcCtD
Escitalopram—Hypokalaemia—Doxorubicin—liver cancer	0.000358	0.000788	CcSEcCtD
Escitalopram—Angina pectoris—Epirubicin—liver cancer	0.000358	0.000788	CcSEcCtD
Escitalopram—Rash—Sorafenib—liver cancer	0.000357	0.000785	CcSEcCtD
Escitalopram—Dermatitis—Sorafenib—liver cancer	0.000356	0.000784	CcSEcCtD
Escitalopram—Breast disorder—Doxorubicin—liver cancer	0.000355	0.000783	CcSEcCtD
Escitalopram—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000354	0.00078	CcSEcCtD
Escitalopram—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000354	0.00078	CcSEcCtD
Escitalopram—Headache—Sorafenib—liver cancer	0.000354	0.00078	CcSEcCtD
Escitalopram—Bronchitis—Epirubicin—liver cancer	0.000353	0.000778	CcSEcCtD
Escitalopram—Nasopharyngitis—Doxorubicin—liver cancer	0.000352	0.000775	CcSEcCtD
Escitalopram—Pancytopenia—Epirubicin—liver cancer	0.000349	0.000769	CcSEcCtD
Escitalopram—Gastritis—Doxorubicin—liver cancer	0.000348	0.000767	CcSEcCtD
Escitalopram—Muscular weakness—Doxorubicin—liver cancer	0.000347	0.000764	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000347	0.000764	CcSEcCtD
Escitalopram—Dysuria—Epirubicin—liver cancer	0.000344	0.000757	CcSEcCtD
Escitalopram—Abdominal distension—Doxorubicin—liver cancer	0.000342	0.000754	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Epirubicin—liver cancer	0.000342	0.000752	CcSEcCtD
Escitalopram—Asthma—Doxorubicin—liver cancer	0.00034	0.000749	CcSEcCtD
Escitalopram—Influenza—Doxorubicin—liver cancer	0.00034	0.000749	CcSEcCtD
Escitalopram—Dysphagia—Doxorubicin—liver cancer	0.00034	0.000749	CcSEcCtD
Escitalopram—Pollakiuria—Epirubicin—liver cancer	0.000339	0.000748	CcSEcCtD
Escitalopram—Eosinophilia—Doxorubicin—liver cancer	0.000337	0.000741	CcSEcCtD
Escitalopram—Nausea—Sorafenib—liver cancer	0.000336	0.00074	CcSEcCtD
Escitalopram—Photosensitivity reaction—Epirubicin—liver cancer	0.000335	0.000739	CcSEcCtD
Escitalopram—Weight increased—Epirubicin—liver cancer	0.000334	0.000736	CcSEcCtD
Escitalopram—Pancreatitis—Doxorubicin—liver cancer	0.000333	0.000734	CcSEcCtD
Escitalopram—Weight decreased—Epirubicin—liver cancer	0.000332	0.000732	CcSEcCtD
Escitalopram—Hyperglycaemia—Epirubicin—liver cancer	0.000331	0.00073	CcSEcCtD
Escitalopram—Angina pectoris—Doxorubicin—liver cancer	0.000331	0.000729	CcSEcCtD
Escitalopram—Pneumonia—Epirubicin—liver cancer	0.00033	0.000726	CcSEcCtD
Escitalopram—Infestation NOS—Epirubicin—liver cancer	0.000328	0.000722	CcSEcCtD
Escitalopram—Infestation—Epirubicin—liver cancer	0.000328	0.000722	CcSEcCtD
Escitalopram—Bronchitis—Doxorubicin—liver cancer	0.000327	0.00072	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000325	0.000715	CcSEcCtD
Escitalopram—Pancytopenia—Doxorubicin—liver cancer	0.000323	0.000711	CcSEcCtD
Escitalopram—Neuropathy peripheral—Epirubicin—liver cancer	0.000321	0.000707	CcSEcCtD
Escitalopram—Jaundice—Epirubicin—liver cancer	0.000319	0.000703	CcSEcCtD
Escitalopram—Stomatitis—Epirubicin—liver cancer	0.000319	0.000703	CcSEcCtD
Escitalopram—Conjunctivitis—Epirubicin—liver cancer	0.000318	0.000701	CcSEcCtD
Escitalopram—Urinary tract infection—Epirubicin—liver cancer	0.000318	0.000701	CcSEcCtD
Escitalopram—Dysuria—Doxorubicin—liver cancer	0.000318	0.0007	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000316	0.000696	CcSEcCtD
Escitalopram—Sweating—Epirubicin—liver cancer	0.000314	0.000692	CcSEcCtD
Escitalopram—Pollakiuria—Doxorubicin—liver cancer	0.000314	0.000692	CcSEcCtD
Escitalopram—Haematuria—Epirubicin—liver cancer	0.000312	0.000688	CcSEcCtD
Escitalopram—Photosensitivity reaction—Doxorubicin—liver cancer	0.00031	0.000683	CcSEcCtD
Escitalopram—Hepatobiliary disease—Epirubicin—liver cancer	0.00031	0.000682	CcSEcCtD
Escitalopram—Weight increased—Doxorubicin—liver cancer	0.000309	0.000681	CcSEcCtD
Escitalopram—Epistaxis—Epirubicin—liver cancer	0.000309	0.000681	CcSEcCtD
Escitalopram—Weight decreased—Doxorubicin—liver cancer	0.000308	0.000677	CcSEcCtD
Escitalopram—Sinusitis—Epirubicin—liver cancer	0.000307	0.000677	CcSEcCtD
Escitalopram—Hyperglycaemia—Doxorubicin—liver cancer	0.000307	0.000675	CcSEcCtD
Escitalopram—Agranulocytosis—Epirubicin—liver cancer	0.000306	0.000673	CcSEcCtD
Escitalopram—Pneumonia—Doxorubicin—liver cancer	0.000305	0.000672	CcSEcCtD
Escitalopram—Infestation—Doxorubicin—liver cancer	0.000303	0.000668	CcSEcCtD
Escitalopram—Infestation NOS—Doxorubicin—liver cancer	0.000303	0.000668	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000301	0.000662	CcSEcCtD
Escitalopram—Bradycardia—Epirubicin—liver cancer	0.000299	0.000659	CcSEcCtD
Escitalopram—Neuropathy peripheral—Doxorubicin—liver cancer	0.000297	0.000654	CcSEcCtD
Escitalopram—Haemoglobin—Epirubicin—liver cancer	0.000296	0.000651	CcSEcCtD
Escitalopram—Stomatitis—Doxorubicin—liver cancer	0.000295	0.000651	CcSEcCtD
Escitalopram—Jaundice—Doxorubicin—liver cancer	0.000295	0.000651	CcSEcCtD
Escitalopram—Rhinitis—Epirubicin—liver cancer	0.000295	0.000649	CcSEcCtD
Escitalopram—Conjunctivitis—Doxorubicin—liver cancer	0.000295	0.000649	CcSEcCtD
Escitalopram—Urinary tract infection—Doxorubicin—liver cancer	0.000295	0.000649	CcSEcCtD
Escitalopram—Haemorrhage—Epirubicin—liver cancer	0.000294	0.000648	CcSEcCtD
Escitalopram—Hepatitis—Epirubicin—liver cancer	0.000294	0.000648	CcSEcCtD
Escitalopram—Hypoaesthesia—Epirubicin—liver cancer	0.000293	0.000644	CcSEcCtD
Escitalopram—Pharyngitis—Epirubicin—liver cancer	0.000292	0.000643	CcSEcCtD
Escitalopram—Sweating—Doxorubicin—liver cancer	0.000291	0.00064	CcSEcCtD
Escitalopram—Urinary tract disorder—Epirubicin—liver cancer	0.00029	0.00064	CcSEcCtD
Escitalopram—Oedema peripheral—Epirubicin—liver cancer	0.00029	0.000638	CcSEcCtD
Escitalopram—Haematuria—Doxorubicin—liver cancer	0.000289	0.000637	CcSEcCtD
Escitalopram—Connective tissue disorder—Epirubicin—liver cancer	0.000289	0.000637	CcSEcCtD
Escitalopram—Urethral disorder—Epirubicin—liver cancer	0.000288	0.000635	CcSEcCtD
Escitalopram—Hepatobiliary disease—Doxorubicin—liver cancer	0.000287	0.000631	CcSEcCtD
Escitalopram—Epistaxis—Doxorubicin—liver cancer	0.000286	0.00063	CcSEcCtD
Escitalopram—Sinusitis—Doxorubicin—liver cancer	0.000284	0.000626	CcSEcCtD
Escitalopram—Visual impairment—Epirubicin—liver cancer	0.000283	0.000624	CcSEcCtD
Escitalopram—Agranulocytosis—Doxorubicin—liver cancer	0.000283	0.000623	CcSEcCtD
Escitalopram—Erythema multiforme—Epirubicin—liver cancer	0.000278	0.000612	CcSEcCtD
Escitalopram—Bradycardia—Doxorubicin—liver cancer	0.000277	0.00061	CcSEcCtD
Escitalopram—Eye disorder—Epirubicin—liver cancer	0.000275	0.000605	CcSEcCtD
Escitalopram—Tinnitus—Epirubicin—liver cancer	0.000274	0.000604	CcSEcCtD
Escitalopram—Haemoglobin—Doxorubicin—liver cancer	0.000274	0.000602	CcSEcCtD
Escitalopram—Flushing—Epirubicin—liver cancer	0.000273	0.000601	CcSEcCtD
Escitalopram—Cardiac disorder—Epirubicin—liver cancer	0.000273	0.000601	CcSEcCtD
Escitalopram—Rhinitis—Doxorubicin—liver cancer	0.000273	0.000601	CcSEcCtD
Escitalopram—Haemorrhage—Doxorubicin—liver cancer	0.000272	0.000599	CcSEcCtD
Escitalopram—Hepatitis—Doxorubicin—liver cancer	0.000272	0.000599	CcSEcCtD
Escitalopram—Hypoaesthesia—Doxorubicin—liver cancer	0.000271	0.000596	CcSEcCtD
Escitalopram—Pharyngitis—Doxorubicin—liver cancer	0.00027	0.000595	CcSEcCtD
Escitalopram—Urinary tract disorder—Doxorubicin—liver cancer	0.000269	0.000592	CcSEcCtD
Escitalopram—Oedema peripheral—Doxorubicin—liver cancer	0.000268	0.00059	CcSEcCtD
Escitalopram—Connective tissue disorder—Doxorubicin—liver cancer	0.000267	0.000589	CcSEcCtD
Escitalopram—Angiopathy—Epirubicin—liver cancer	0.000267	0.000588	CcSEcCtD
Escitalopram—Urethral disorder—Doxorubicin—liver cancer	0.000267	0.000588	CcSEcCtD
Escitalopram—Immune system disorder—Epirubicin—liver cancer	0.000266	0.000585	CcSEcCtD
Escitalopram—Mediastinal disorder—Epirubicin—liver cancer	0.000265	0.000584	CcSEcCtD
Escitalopram—Chills—Epirubicin—liver cancer	0.000264	0.000581	CcSEcCtD
Escitalopram—Arrhythmia—Epirubicin—liver cancer	0.000263	0.000579	CcSEcCtD
Escitalopram—Visual impairment—Doxorubicin—liver cancer	0.000262	0.000578	CcSEcCtD
Escitalopram—Alopecia—Epirubicin—liver cancer	0.00026	0.000572	CcSEcCtD
Escitalopram—Mental disorder—Epirubicin—liver cancer	0.000258	0.000567	CcSEcCtD
Escitalopram—Erythema multiforme—Doxorubicin—liver cancer	0.000257	0.000567	CcSEcCtD
Escitalopram—Erythema—Epirubicin—liver cancer	0.000256	0.000564	CcSEcCtD
Escitalopram—Malnutrition—Epirubicin—liver cancer	0.000256	0.000564	CcSEcCtD
Escitalopram—Eye disorder—Doxorubicin—liver cancer	0.000254	0.00056	CcSEcCtD
Escitalopram—Tinnitus—Doxorubicin—liver cancer	0.000254	0.000559	CcSEcCtD
Escitalopram—Flushing—Doxorubicin—liver cancer	0.000253	0.000556	CcSEcCtD
Escitalopram—Cardiac disorder—Doxorubicin—liver cancer	0.000253	0.000556	CcSEcCtD
Escitalopram—Flatulence—Epirubicin—liver cancer	0.000252	0.000556	CcSEcCtD
Escitalopram—Tension—Epirubicin—liver cancer	0.000251	0.000553	CcSEcCtD
Escitalopram—Dysgeusia—Epirubicin—liver cancer	0.000251	0.000552	CcSEcCtD
Escitalopram—Nervousness—Epirubicin—liver cancer	0.000249	0.000548	CcSEcCtD
Escitalopram—Back pain—Epirubicin—liver cancer	0.000248	0.000545	CcSEcCtD
Escitalopram—Angiopathy—Doxorubicin—liver cancer	0.000247	0.000544	CcSEcCtD
Escitalopram—Muscle spasms—Epirubicin—liver cancer	0.000246	0.000542	CcSEcCtD
Escitalopram—Immune system disorder—Doxorubicin—liver cancer	0.000246	0.000541	CcSEcCtD
Escitalopram—Mediastinal disorder—Doxorubicin—liver cancer	0.000245	0.00054	CcSEcCtD
Escitalopram—Chills—Doxorubicin—liver cancer	0.000244	0.000538	CcSEcCtD
Escitalopram—Arrhythmia—Doxorubicin—liver cancer	0.000243	0.000535	CcSEcCtD
Escitalopram—Vision blurred—Epirubicin—liver cancer	0.000241	0.000531	CcSEcCtD
Escitalopram—Alopecia—Doxorubicin—liver cancer	0.00024	0.00053	CcSEcCtD
Escitalopram—Mental disorder—Doxorubicin—liver cancer	0.000238	0.000525	CcSEcCtD
Escitalopram—Ill-defined disorder—Epirubicin—liver cancer	0.000238	0.000523	CcSEcCtD
Escitalopram—Erythema—Doxorubicin—liver cancer	0.000237	0.000522	CcSEcCtD
Escitalopram—Malnutrition—Doxorubicin—liver cancer	0.000237	0.000522	CcSEcCtD
Escitalopram—Anaemia—Epirubicin—liver cancer	0.000237	0.000521	CcSEcCtD
Escitalopram—Agitation—Epirubicin—liver cancer	0.000235	0.000518	CcSEcCtD
Escitalopram—Flatulence—Doxorubicin—liver cancer	0.000233	0.000514	CcSEcCtD
Escitalopram—Tension—Doxorubicin—liver cancer	0.000232	0.000512	CcSEcCtD
Escitalopram—Dysgeusia—Doxorubicin—liver cancer	0.000232	0.000511	CcSEcCtD
Escitalopram—Malaise—Epirubicin—liver cancer	0.000231	0.000508	CcSEcCtD
Escitalopram—Nervousness—Doxorubicin—liver cancer	0.00023	0.000507	CcSEcCtD
Escitalopram—Vertigo—Epirubicin—liver cancer	0.00023	0.000507	CcSEcCtD
Escitalopram—Syncope—Epirubicin—liver cancer	0.00023	0.000506	CcSEcCtD
Escitalopram—Leukopenia—Epirubicin—liver cancer	0.000229	0.000505	CcSEcCtD
Escitalopram—Back pain—Doxorubicin—liver cancer	0.000229	0.000505	CcSEcCtD
Escitalopram—Muscle spasms—Doxorubicin—liver cancer	0.000228	0.000502	CcSEcCtD
Escitalopram—Palpitations—Epirubicin—liver cancer	0.000226	0.000498	CcSEcCtD
Escitalopram—Loss of consciousness—Epirubicin—liver cancer	0.000225	0.000496	CcSEcCtD
Escitalopram—Cough—Epirubicin—liver cancer	0.000223	0.000492	CcSEcCtD
Escitalopram—Vision blurred—Doxorubicin—liver cancer	0.000223	0.000492	CcSEcCtD
Escitalopram—Convulsion—Epirubicin—liver cancer	0.000222	0.000489	CcSEcCtD
Escitalopram—Hypertension—Epirubicin—liver cancer	0.000221	0.000487	CcSEcCtD
Escitalopram—Ill-defined disorder—Doxorubicin—liver cancer	0.00022	0.000484	CcSEcCtD
Escitalopram—Anaemia—Doxorubicin—liver cancer	0.000219	0.000482	CcSEcCtD
Escitalopram—Arthralgia—Epirubicin—liver cancer	0.000218	0.00048	CcSEcCtD
Escitalopram—Chest pain—Epirubicin—liver cancer	0.000218	0.00048	CcSEcCtD
Escitalopram—Myalgia—Epirubicin—liver cancer	0.000218	0.00048	CcSEcCtD
Escitalopram—Agitation—Doxorubicin—liver cancer	0.000218	0.000479	CcSEcCtD
Escitalopram—Anxiety—Epirubicin—liver cancer	0.000217	0.000478	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000216	0.000477	CcSEcCtD
Escitalopram—Discomfort—Epirubicin—liver cancer	0.000215	0.000474	CcSEcCtD
Escitalopram—Malaise—Doxorubicin—liver cancer	0.000214	0.00047	CcSEcCtD
Escitalopram—Dry mouth—Epirubicin—liver cancer	0.000213	0.000469	CcSEcCtD
Escitalopram—Vertigo—Doxorubicin—liver cancer	0.000213	0.000469	CcSEcCtD
Escitalopram—Syncope—Doxorubicin—liver cancer	0.000212	0.000468	CcSEcCtD
Escitalopram—Leukopenia—Doxorubicin—liver cancer	0.000212	0.000467	CcSEcCtD
Escitalopram—Confusional state—Epirubicin—liver cancer	0.000211	0.000464	CcSEcCtD
Escitalopram—Palpitations—Doxorubicin—liver cancer	0.000209	0.000461	CcSEcCtD
Escitalopram—Oedema—Epirubicin—liver cancer	0.000209	0.00046	CcSEcCtD
Escitalopram—Anaphylactic shock—Epirubicin—liver cancer	0.000209	0.00046	CcSEcCtD
Escitalopram—Loss of consciousness—Doxorubicin—liver cancer	0.000208	0.000459	CcSEcCtD
Escitalopram—Infection—Epirubicin—liver cancer	0.000208	0.000457	CcSEcCtD
Escitalopram—Cough—Doxorubicin—liver cancer	0.000207	0.000455	CcSEcCtD
Escitalopram—Shock—Epirubicin—liver cancer	0.000206	0.000453	CcSEcCtD
Escitalopram—Convulsion—Doxorubicin—liver cancer	0.000205	0.000452	CcSEcCtD
Escitalopram—Nervous system disorder—Epirubicin—liver cancer	0.000205	0.000451	CcSEcCtD
Escitalopram—Thrombocytopenia—Epirubicin—liver cancer	0.000205	0.000451	CcSEcCtD
Escitalopram—Hypertension—Doxorubicin—liver cancer	0.000205	0.00045	CcSEcCtD
Escitalopram—Tachycardia—Epirubicin—liver cancer	0.000204	0.000449	CcSEcCtD
Escitalopram—Skin disorder—Epirubicin—liver cancer	0.000203	0.000447	CcSEcCtD
Escitalopram—Hyperhidrosis—Epirubicin—liver cancer	0.000202	0.000445	CcSEcCtD
Escitalopram—Myalgia—Doxorubicin—liver cancer	0.000202	0.000444	CcSEcCtD
Escitalopram—Arthralgia—Doxorubicin—liver cancer	0.000202	0.000444	CcSEcCtD
Escitalopram—Chest pain—Doxorubicin—liver cancer	0.000202	0.000444	CcSEcCtD
Escitalopram—Anxiety—Doxorubicin—liver cancer	0.000201	0.000443	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0002	0.000441	CcSEcCtD
Escitalopram—Discomfort—Doxorubicin—liver cancer	0.000199	0.000439	CcSEcCtD
Escitalopram—Anorexia—Epirubicin—liver cancer	0.000199	0.000439	CcSEcCtD
Escitalopram—Dry mouth—Doxorubicin—liver cancer	0.000197	0.000434	CcSEcCtD
Escitalopram—Hypotension—Epirubicin—liver cancer	0.000195	0.00043	CcSEcCtD
Escitalopram—Confusional state—Doxorubicin—liver cancer	0.000195	0.000429	CcSEcCtD
Escitalopram—Oedema—Doxorubicin—liver cancer	0.000193	0.000426	CcSEcCtD
Escitalopram—Anaphylactic shock—Doxorubicin—liver cancer	0.000193	0.000426	CcSEcCtD
Escitalopram—Infection—Doxorubicin—liver cancer	0.000192	0.000423	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00019	0.000419	CcSEcCtD
Escitalopram—Shock—Doxorubicin—liver cancer	0.00019	0.000419	CcSEcCtD
Escitalopram—Nervous system disorder—Doxorubicin—liver cancer	0.00019	0.000418	CcSEcCtD
Escitalopram—Thrombocytopenia—Doxorubicin—liver cancer	0.000189	0.000417	CcSEcCtD
Escitalopram—Insomnia—Epirubicin—liver cancer	0.000189	0.000416	CcSEcCtD
Escitalopram—Tachycardia—Doxorubicin—liver cancer	0.000189	0.000416	CcSEcCtD
Escitalopram—Skin disorder—Doxorubicin—liver cancer	0.000188	0.000414	CcSEcCtD
Escitalopram—Paraesthesia—Epirubicin—liver cancer	0.000188	0.000413	CcSEcCtD
Escitalopram—Hyperhidrosis—Doxorubicin—liver cancer	0.000187	0.000412	CcSEcCtD
Escitalopram—Dyspnoea—Epirubicin—liver cancer	0.000186	0.00041	CcSEcCtD
Escitalopram—Somnolence—Epirubicin—liver cancer	0.000186	0.000409	CcSEcCtD
Escitalopram—Anorexia—Doxorubicin—liver cancer	0.000184	0.000406	CcSEcCtD
Escitalopram—Dyspepsia—Epirubicin—liver cancer	0.000184	0.000405	CcSEcCtD
Escitalopram—Decreased appetite—Epirubicin—liver cancer	0.000182	0.0004	CcSEcCtD
Escitalopram—Hypotension—Doxorubicin—liver cancer	0.000181	0.000398	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Epirubicin—liver cancer	0.00018	0.000397	CcSEcCtD
Escitalopram—Fatigue—Epirubicin—liver cancer	0.00018	0.000397	CcSEcCtD
Escitalopram—Pain—Epirubicin—liver cancer	0.000179	0.000394	CcSEcCtD
Escitalopram—Constipation—Epirubicin—liver cancer	0.000179	0.000394	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000176	0.000388	CcSEcCtD
Escitalopram—Insomnia—Doxorubicin—liver cancer	0.000175	0.000385	CcSEcCtD
Escitalopram—Paraesthesia—Doxorubicin—liver cancer	0.000174	0.000382	CcSEcCtD
Escitalopram—Dyspnoea—Doxorubicin—liver cancer	0.000172	0.00038	CcSEcCtD
Escitalopram—Feeling abnormal—Epirubicin—liver cancer	0.000172	0.000379	CcSEcCtD
Escitalopram—Somnolence—Doxorubicin—liver cancer	0.000172	0.000379	CcSEcCtD
Escitalopram—Gastrointestinal pain—Epirubicin—liver cancer	0.000171	0.000376	CcSEcCtD
Escitalopram—Dyspepsia—Doxorubicin—liver cancer	0.00017	0.000375	CcSEcCtD
Escitalopram—Decreased appetite—Doxorubicin—liver cancer	0.000168	0.00037	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000167	0.000368	CcSEcCtD
Escitalopram—Fatigue—Doxorubicin—liver cancer	0.000167	0.000367	CcSEcCtD
Escitalopram—Urticaria—Epirubicin—liver cancer	0.000166	0.000366	CcSEcCtD
Escitalopram—Constipation—Doxorubicin—liver cancer	0.000165	0.000364	CcSEcCtD
Escitalopram—Pain—Doxorubicin—liver cancer	0.000165	0.000364	CcSEcCtD
Escitalopram—Abdominal pain—Epirubicin—liver cancer	0.000165	0.000364	CcSEcCtD
Escitalopram—Body temperature increased—Epirubicin—liver cancer	0.000165	0.000364	CcSEcCtD
Escitalopram—Feeling abnormal—Doxorubicin—liver cancer	0.000159	0.000351	CcSEcCtD
Escitalopram—Gastrointestinal pain—Doxorubicin—liver cancer	0.000158	0.000348	CcSEcCtD
Escitalopram—Hypersensitivity—Epirubicin—liver cancer	0.000154	0.000339	CcSEcCtD
Escitalopram—Urticaria—Doxorubicin—liver cancer	0.000154	0.000338	CcSEcCtD
Escitalopram—Abdominal pain—Doxorubicin—liver cancer	0.000153	0.000337	CcSEcCtD
Escitalopram—Body temperature increased—Doxorubicin—liver cancer	0.000153	0.000337	CcSEcCtD
Escitalopram—Asthenia—Epirubicin—liver cancer	0.00015	0.00033	CcSEcCtD
Escitalopram—Pruritus—Epirubicin—liver cancer	0.000148	0.000326	CcSEcCtD
Escitalopram—Diarrhoea—Epirubicin—liver cancer	0.000143	0.000315	CcSEcCtD
Escitalopram—Hypersensitivity—Doxorubicin—liver cancer	0.000142	0.000314	CcSEcCtD
Escitalopram—Asthenia—Doxorubicin—liver cancer	0.000139	0.000306	CcSEcCtD
Escitalopram—Dizziness—Epirubicin—liver cancer	0.000138	0.000304	CcSEcCtD
Escitalopram—Pruritus—Doxorubicin—liver cancer	0.000137	0.000301	CcSEcCtD
Escitalopram—Vomiting—Epirubicin—liver cancer	0.000133	0.000293	CcSEcCtD
Escitalopram—Diarrhoea—Doxorubicin—liver cancer	0.000132	0.000291	CcSEcCtD
Escitalopram—Rash—Epirubicin—liver cancer	0.000132	0.00029	CcSEcCtD
Escitalopram—Dermatitis—Epirubicin—liver cancer	0.000132	0.00029	CcSEcCtD
Escitalopram—Headache—Epirubicin—liver cancer	0.000131	0.000288	CcSEcCtD
Escitalopram—Dizziness—Doxorubicin—liver cancer	0.000128	0.000282	CcSEcCtD
Escitalopram—Nausea—Epirubicin—liver cancer	0.000124	0.000273	CcSEcCtD
Escitalopram—Vomiting—Doxorubicin—liver cancer	0.000123	0.000271	CcSEcCtD
Escitalopram—Rash—Doxorubicin—liver cancer	0.000122	0.000268	CcSEcCtD
Escitalopram—Dermatitis—Doxorubicin—liver cancer	0.000122	0.000268	CcSEcCtD
Escitalopram—Headache—Doxorubicin—liver cancer	0.000121	0.000267	CcSEcCtD
Escitalopram—Nausea—Doxorubicin—liver cancer	0.000115	0.000253	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—PRKCE—liver cancer	2.3e-05	0.000213	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CD—liver cancer	2.28e-05	0.00021	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT2—liver cancer	2.28e-05	0.00021	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	2.23e-05	0.000206	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF2—liver cancer	2.22e-05	0.000206	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.22e-05	0.000205	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF2—liver cancer	2.22e-05	0.000205	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CB—liver cancer	2.19e-05	0.000202	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF2—liver cancer	2.18e-05	0.000202	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PSMA4—liver cancer	2.15e-05	0.000199	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PSMD10—liver cancer	2.15e-05	0.000199	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL2—liver cancer	2.14e-05	0.000198	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2E1—liver cancer	2.14e-05	0.000198	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TERT—liver cancer	2.14e-05	0.000197	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTA4—liver cancer	2.12e-05	0.000196	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT2—liver cancer	2.09e-05	0.000194	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CSF2—liver cancer	2.08e-05	0.000192	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.07e-05	0.000192	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—RAF1—liver cancer	2.07e-05	0.000191	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTA2—liver cancer	2.07e-05	0.000191	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CSF2—liver cancer	2.07e-05	0.000191	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—RAF1—liver cancer	2.07e-05	0.000191	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—H2AFX—liver cancer	2.05e-05	0.000189	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL2—liver cancer	2.05e-05	0.000189	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—H2AFX—liver cancer	2.04e-05	0.000189	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL2—liver cancer	2.04e-05	0.000188	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CSF2—liver cancer	2.04e-05	0.000188	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—RAF1—liver cancer	2.03e-05	0.000188	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CB—liver cancer	2.02e-05	0.000187	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	2.02e-05	0.000186	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—H2AFX—liver cancer	2.01e-05	0.000186	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL2—liver cancer	2.01e-05	0.000186	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYCS—liver cancer	2e-05	0.000185	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTA1—liver cancer	2e-05	0.000185	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	1.98e-05	0.000183	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NAT2—liver cancer	1.98e-05	0.000183	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2E1—liver cancer	1.97e-05	0.000182	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GGT1—liver cancer	1.97e-05	0.000182	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT1—liver cancer	1.97e-05	0.000182	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KDR—liver cancer	1.95e-05	0.000181	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK14—liver cancer	1.94e-05	0.000179	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ESR1—liver cancer	1.9e-05	0.000176	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDOB—liver cancer	1.89e-05	0.000175	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—F2—liver cancer	1.88e-05	0.000174	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL2—liver cancer	1.86e-05	0.000172	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL2—liver cancer	1.85e-05	0.000171	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TERT—liver cancer	1.85e-05	0.000171	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TERT—liver cancer	1.85e-05	0.000171	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYCS—liver cancer	1.84e-05	0.00017	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL2—liver cancer	1.82e-05	0.000168	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TERT—liver cancer	1.82e-05	0.000168	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT1—liver cancer	1.81e-05	0.000167	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT1—liver cancer	1.81e-05	0.000167	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CRABP1—liver cancer	1.81e-05	0.000167	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APC—liver cancer	1.8e-05	0.000166	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CG—liver cancer	1.8e-05	0.000166	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTP1—liver cancer	1.77e-05	0.000163	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—liver cancer	1.74e-05	0.000161	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KDR—liver cancer	1.69e-05	0.000156	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—BRAF—liver cancer	1.69e-05	0.000156	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KDR—liver cancer	1.69e-05	0.000156	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK14—liver cancer	1.68e-05	0.000155	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK14—liver cancer	1.68e-05	0.000155	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KDR—liver cancer	1.66e-05	0.000154	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK14—liver cancer	1.65e-05	0.000153	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—liver cancer	1.65e-05	0.000152	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—liver cancer	1.64e-05	0.000152	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—liver cancer	1.63e-05	0.000151	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—liver cancer	1.62e-05	0.00015	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTP1—liver cancer	1.62e-05	0.00015	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—liver cancer	1.62e-05	0.00015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—liver cancer	1.62e-05	0.00015	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—liver cancer	1.6e-05	0.000148	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—liver cancer	1.6e-05	0.000148	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CD—liver cancer	1.58e-05	0.000146	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HPGDS—liver cancer	1.58e-05	0.000146	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PIK3CA—liver cancer	1.57e-05	0.000145	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—liver cancer	1.56e-05	0.000145	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APC—liver cancer	1.56e-05	0.000144	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CG—liver cancer	1.56e-05	0.000144	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APC—liver cancer	1.55e-05	0.000144	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CG—liver cancer	1.55e-05	0.000144	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—KRAS—liver cancer	1.55e-05	0.000143	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1A1—liver cancer	1.54e-05	0.000142	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	1.53e-05	0.000141	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APC—liver cancer	1.53e-05	0.000141	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—liver cancer	1.49e-05	0.000138	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—BRAF—liver cancer	1.47e-05	0.000135	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—BRAF—liver cancer	1.46e-05	0.000135	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—BRAF—liver cancer	1.44e-05	0.000133	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—liver cancer	1.43e-05	0.000133	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PIK3CA—liver cancer	1.42e-05	0.000132	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000131	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RAF1—liver cancer	1.41e-05	0.000131	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMA4—liver cancer	1.41e-05	0.00013	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMD10—liver cancer	1.41e-05	0.00013	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—liver cancer	1.41e-05	0.00013	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CB—liver cancer	1.38e-05	0.000127	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MTOR—liver cancer	1.38e-05	0.000127	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CD—liver cancer	1.37e-05	0.000127	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT2—liver cancer	1.37e-05	0.000127	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CD—liver cancer	1.37e-05	0.000126	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	1.36e-05	0.000125	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—liver cancer	1.36e-05	0.000125	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.35e-05	0.000125	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—liver cancer	1.35e-05	0.000125	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	1.35e-05	0.000124	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—KRAS—liver cancer	1.34e-05	0.000124	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—KRAS—liver cancer	1.34e-05	0.000124	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	1.33e-05	0.000123	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	1.33e-05	0.000123	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—liver cancer	1.32e-05	0.000122	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—KRAS—liver cancer	1.32e-05	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HRAS—liver cancer	1.32e-05	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN1B—liver cancer	1.29e-05	0.00012	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—liver cancer	1.29e-05	0.00012	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2E1—liver cancer	1.29e-05	0.000119	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—liver cancer	1.28e-05	0.000118	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CASP3—liver cancer	1.27e-05	0.000117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL2—liver cancer	1.27e-05	0.000117	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.26e-05	0.000117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—liver cancer	1.26e-05	0.000116	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCND1—liver cancer	1.23e-05	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CA—liver cancer	1.23e-05	0.000114	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—JUN—liver cancer	1.23e-05	0.000114	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	1.23e-05	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RAF1—liver cancer	1.22e-05	0.000113	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CTNNB1—liver cancer	1.22e-05	0.000113	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RAF1—liver cancer	1.22e-05	0.000113	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	1.21e-05	0.000112	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CG—liver cancer	1.2e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYCS—liver cancer	1.2e-05	0.000111	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RAF1—liver cancer	1.2e-05	0.000111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—liver cancer	1.2e-05	0.000111	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CB—liver cancer	1.19e-05	0.00011	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MTOR—liver cancer	1.19e-05	0.00011	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN1A—liver cancer	1.19e-05	0.00011	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CB—liver cancer	1.19e-05	0.00011	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MTOR—liver cancer	1.19e-05	0.00011	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT1—liver cancer	1.18e-05	0.000109	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—liver cancer	1.18e-05	0.000109	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MTOR—liver cancer	1.17e-05	0.000108	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	1.17e-05	0.000108	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK8—liver cancer	1.17e-05	0.000108	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—liver cancer	1.16e-05	0.000107	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—liver cancer	1.16e-05	0.000107	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HRAS—liver cancer	1.14e-05	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HRAS—liver cancer	1.14e-05	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN1B—liver cancer	1.12e-05	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HRAS—liver cancer	1.12e-05	0.000103	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN1B—liver cancer	1.12e-05	0.000103	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—liver cancer	1.11e-05	0.000103	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CG—liver cancer	1.11e-05	0.000102	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—liver cancer	1.11e-05	0.000102	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	1.1e-05	0.000102	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CASP3—liver cancer	1.1e-05	0.000102	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL2—liver cancer	1.1e-05	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CASP3—liver cancer	1.1e-05	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL2—liver cancer	1.09e-05	0.000101	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—liver cancer	1.09e-05	0.000101	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	1.09e-05	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—liver cancer	1.09e-05	0.000101	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CASP3—liver cancer	1.08e-05	9.97e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL2—liver cancer	1.08e-05	9.95e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—liver cancer	1.08e-05	9.95e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—liver cancer	1.07e-05	9.9e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCND1—liver cancer	1.07e-05	9.89e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—liver cancer	1.07e-05	9.88e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JUN—liver cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCND1—liver cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—liver cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JUN—liver cancer	1.06e-05	9.83e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTP1—liver cancer	1.06e-05	9.81e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CTNNB1—liver cancer	1.06e-05	9.79e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CD—liver cancer	1.06e-05	9.79e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CTNNB1—liver cancer	1.06e-05	9.76e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCND1—liver cancer	1.05e-05	9.7e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JUN—liver cancer	1.05e-05	9.68e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—liver cancer	1.05e-05	9.68e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—liver cancer	1.05e-05	9.66e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	1.04e-05	9.61e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—liver cancer	1.04e-05	9.6e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—liver cancer	1.04e-05	9.57e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN1A—liver cancer	1.03e-05	9.56e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN1A—liver cancer	1.03e-05	9.53e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—liver cancer	1.02e-05	9.42e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	1.02e-05	9.38e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK8—liver cancer	1.01e-05	9.33e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—liver cancer	1.01e-05	9.31e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK8—liver cancer	1.01e-05	9.3e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—liver cancer	1e-05	9.28e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK8—liver cancer	9.91e-06	9.16e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—liver cancer	9.9e-06	9.15e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—liver cancer	9.88e-06	9.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—liver cancer	9.88e-06	9.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—liver cancer	9.76e-06	9.02e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CD—liver cancer	9.74e-06	9e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—liver cancer	9.62e-06	8.89e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—liver cancer	9.33e-06	8.62e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—liver cancer	9.3e-06	8.59e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A1—liver cancer	9.25e-06	8.55e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—liver cancer	9.23e-06	8.53e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CB—liver cancer	9.23e-06	8.53e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—liver cancer	9.21e-06	8.51e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—liver cancer	9.15e-06	8.46e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KRAS—liver cancer	9.15e-06	8.46e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—liver cancer	9.06e-06	8.37e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—liver cancer	8.62e-06	7.97e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—liver cancer	8.58e-06	7.93e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—liver cancer	8.56e-06	7.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—liver cancer	8.55e-06	7.9e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—liver cancer	8.53e-06	7.89e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CB—liver cancer	8.49e-06	7.85e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—liver cancer	8.46e-06	7.82e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—liver cancer	8.42e-06	7.78e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CA—liver cancer	8.41e-06	7.77e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—liver cancer	8.4e-06	7.76e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—liver cancer	8.13e-06	7.52e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KRAS—liver cancer	7.93e-06	7.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KRAS—liver cancer	7.9e-06	7.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KRAS—liver cancer	7.78e-06	7.19e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HRAS—liver cancer	7.78e-06	7.19e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—liver cancer	7.44e-06	6.88e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CA—liver cancer	7.28e-06	6.73e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CA—liver cancer	7.26e-06	6.71e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CG—liver cancer	7.24e-06	6.69e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	7.15e-06	6.61e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—liver cancer	7.05e-06	6.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—liver cancer	7.02e-06	6.49e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—liver cancer	6.99e-06	6.46e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—liver cancer	6.92e-06	6.39e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—liver cancer	6.87e-06	6.35e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HRAS—liver cancer	6.74e-06	6.23e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HRAS—liver cancer	6.72e-06	6.21e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HRAS—liver cancer	6.61e-06	6.11e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—liver cancer	6.45e-06	5.96e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—liver cancer	6.43e-06	5.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CD—liver cancer	6.37e-06	5.89e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—liver cancer	6.33e-06	5.85e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—liver cancer	6.29e-06	5.81e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—liver cancer	5.95e-06	5.5e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—liver cancer	5.93e-06	5.48e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—liver cancer	5.84e-06	5.4e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CA—liver cancer	5.63e-06	5.2e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CB—liver cancer	5.55e-06	5.13e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CA—liver cancer	5.18e-06	4.78e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—liver cancer	4.6e-06	4.25e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—liver cancer	4.23e-06	3.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CA—liver cancer	3.38e-06	3.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—liver cancer	2.76e-06	2.55e-05	CbGpPWpGaD
